Federal regulators and researchers now focus not only on the plant itself, but also on how psychoactive compounds are concentrated, how products are promoted to consumers, and whether sellers blur the line between a raw botanical and a drug-like product
Botfield HF, Uldall MS, Westgate CSJ, Mitchell JL, Hagen SM, Gonzalez AM, Hodson DJ, Jensen RH, Sinclair AJ (2017) A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus
We are treating patients with valve abnormalities without having to open their chests, thus providing a much less invasive procedure
It helps you track patterns, understand your GLP-1 routine, and prepare better conversations with your clinician
This slow titration helps reduce gastrointestinal (GI) discomfort
GLP-3(Reta): Triple Agonism and the Energy Expenditure Variable GLP-3(Reta) is where the metabolic research community has focused its most intense attention in 2025-2026